Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Coeptis Therapeutics Holdings (COEP) Invested Capital (2021 - 2025)

Historic Invested Capital for Coeptis Therapeutics Holdings (COEP) over the last 5 years, with Q3 2025 value amounting to $10.9 million.

  • Coeptis Therapeutics Holdings' Invested Capital rose 11910.61% to $10.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.9 million, marking a year-over-year increase of 11910.61%. This contributed to the annual value of $4.9 million for FY2024, which is 50306.23% up from last year.
  • As of Q3 2025, Coeptis Therapeutics Holdings' Invested Capital stood at $10.9 million, which was up 11910.61% from $7.1 million recorded in Q2 2025.
  • Over the past 5 years, Coeptis Therapeutics Holdings' Invested Capital peaked at $10.9 million during Q3 2025, and registered a low of -$5.6 million during Q3 2021.
  • Moreover, its 5-year median value for Invested Capital was $2.4 million (2021), whereas its average is $3.3 million.
  • Its Invested Capital has fluctuated over the past 5 years, first tumbled by 23476.2% in 2024, then soared by 238347.09% in 2025.
  • Coeptis Therapeutics Holdings' Invested Capital (Quarter) stood at $2.4 million in 2021, then skyrocketed by 89.45% to $4.5 million in 2022, then plummeted by 81.72% to $813964.0 in 2023, then soared by 503.06% to $4.9 million in 2024, then soared by 122.4% to $10.9 million in 2025.
  • Its last three reported values are $10.9 million in Q3 2025, $7.1 million for Q2 2025, and $8.1 million during Q1 2025.